# Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension

> **NCT01572077** · NA · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **RADIATION:** FTHA, FDG PET imaging.

## Key facts

- **NCT ID:** NCT01572077
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-07-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572077, "Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01572077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*